Sonoma Pharmaceuticals Ownership | Who Owns Sonoma Pharmaceuticals?


OverviewRevenueFinancialsChart

Sonoma Pharmaceuticals Ownership Summary


Sonoma Pharmaceuticals is owned by 2.56% institutional investors, 0.57% insiders, and 96.87% retail investors. Citadel advisors is the largest institutional shareholder, holding 1.25% of SNOA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.54% of its assets in Sonoma Pharmaceuticals shares.

SNOA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSonoma Pharmaceuticals2.56%0.57%96.87%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Citadel advisors195.16K1.25%$41.41K
Geode capital management19.94K1.16%$42.47K
Vanguard group18.89K1.15%$68.75K
Drw securities12.02K0.70%$25.59K
Mckinley carter wealth services11.19K0.65%$23.84K
State street24.32K0.16%$5.16K
Morgan stanley2.00K0.12%$4.27K
Citigroup1.43K0.08%$3.04K
Tower research capital llc (trc)1.23K0.07%$2.62K
Global retirement partners772.000.05%$2.81K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mckinley carter wealth services11.19K0.00%$23.84K
Drw securities12.02K0.00%$25.59K
Tower research capital llc (trc)1.23K0.00%$2.62K
Heron bay capital management---
Blackrock2.27K-$481.00
Cwm1.00-$2.00
Two sigma securities---
Renaissance---
Susquehanna group, llp---
Rockefeller capital management646.00-$2.51K

Top Buyers

HolderShares% AssetsChange
Citadel advisors195.16K-195.16K
Geode capital management19.94K-4.03K
Morgan stanley2.00K-2.00K
Citigroup1.43K-1.43K
Tower research capital llc (trc)1.23K0.00%846.00

Top Sellers

HolderShares% AssetsChange
Drw securities12.02K0.00%-48.96K
Susquehanna group, llp---46.05K
Jane street group---45.30K
Heron bay capital management---33.78K
Xtx topco---19.83K

New Positions

HolderShares% AssetsChangeValue
Rockefeller capital management646.00-646.00$2.51K
Vanguard fiduciary trust100.00-100.00$213.00
Fmr2.00-2.00$7.00
Caitong asset management1.00-1.00$2.00
Cwm1.00-1.00$2.00

Sold Out

HolderChange
Sbi securities-1.00
Allworth financial lp-3.00
Mai capital management-124.00
Qube research-3.40K
Hrt financial lp-11.84K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202611-26.67%43,767-59.81%26.32%5-1-80.00%
Dec 31, 202512-36.84%108,01081.96%650.15%3-72.73%4300.00%
Sep 30, 20251863.64%59,357-30.08%313.52%12140.00%1-50.00%
Jun 30, 202512-84,901156.84%5101.48%5-2-
Mar 31, 20251233.33%33,05663.98%2119.08%5150.00%2100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr18.79K0.54%-
Fidelity Extended Market Index13.98K0.40%4.03K
Spartan Extended Market Index Pool E2.97K0.18%2.92K
Fidelity Total Market Index2.53K0.07%-
Fidelity Series Total Market Index2.31K0.07%-
Spartan Total Market Index Pool G1.04K0.03%-
Fidelity Nasdaq Composite Index248.000.02%-
NT Ext Equity Mkt Idx Fd - L96.000.01%-
JHVIT Total Stock Market Index I62.000.00%62.00
NT Ext Equity Mkt Index Fund - Lending96.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 12, 2018Miller Robert E Chief Financial OfficerBuy$4.84K
Mar 13, 2018Miller Robert E Chief Financial OfficerBuy$4.92K
Mar 12, 2018Miller Robert E Chief Financial OfficerBuy$4.84K
Mar 09, 2018Miller Robert E Chief Financial OfficerBuy$4.68K
Mar 08, 2018Schutz James J Chief Executive OfficerBuy$9.87K

Insider Transactions Trends


DateBuySell
2027 Q1--
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q2--

SNOA Ownership FAQ


Who Owns Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals shareholders are primarily institutional investors at 2.56%, followed by 0.57% insiders and 96.88% retail investors. The average institutional ownership in Sonoma Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Sonoma Pharmaceuticals falls below.

Who owns the most shares of Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals’s largest shareholders are Citadel advisors (195.16K shares, 1.25%), Geode capital management (19.94K shares, 1.16%), and Vanguard group (18.89K shares, 1.15%). Together, they hold 3.56% of Sonoma Pharmaceuticals’s total shares outstanding.

Does Blackrock own Sonoma Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Sonoma Pharmaceuticals.

Who is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Mckinley carter wealth services is Sonoma Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 11.19K Sonoma Pharmaceuticals shares, valued at 23.84K$.

Who is the top mutual fund holder of Sonoma Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Sonoma Pharmaceuticals shares, with 0.54% of its total shares outstanding invested in 18.79K Sonoma Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools